ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

QB

Qihan Biotech at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Qihan Biotech brings 5 presentations to ACR Convergence 2026 in Orlando. Its program centres on CAR-T cell therapy for autoimmune disease, with work on allogeneic CD19/BCMA products in refractory lupus and immune thrombocytopenia tied to connective tissue disease. It also covers ways to engineer universal CAR-T cells that last longer.

OrganizationACR Convergence 2026 Attendance
QB
Qihan Biotech
Hangzhou, China
Biotech companies
Biotechnology company developing engineered cell therapies, including CAR-T products.

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Qihan Biotech

Tell us what you sell and we’ll find the people at Qihan Biotech most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction